Loading ...

gemcitabine-loaded PLGA nanoparticles

Based on

2 Articles
2013 Most recent source

Composition

1

poly(lactic-co-glycolic acid)

PLGA
Type Polymer
Formula
Role carriers
2

(4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl]-1,2-dihydropyrimidin-2-one)

2',2'-difluoro-2'-deoxycytidine 2'-deoxy-2',2'-difluorocytidine 2',2'-difluorodeoxycytidine gemcitabine gemzar dFdC GEM Gem gem
Type Single Compound
Formula C9H11F2N3O4
Role loaded material

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
drug entrapment efficiency

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
scanning electron microscopy

More information/entries available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
human pancreatic carcinoma PANC-1 cells

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • poly(lactic-co-glycolic acid)
  • (4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl]-1,2-dihydropyrimidin-2-one)
  1. afPt5NwIeWdHDd
  2. Qpc
  3. 4IIlG
  4. fS54LgPFFc
Product

gemcitabine-loaded PLGA nanoparticles

Diameter: 169.5 - 186.5 nm

Medium/Support: none

Method 2

Type: Physical formation
Source:
Starting materials
  • (4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl]-1,2-dihydropyrimidin-2-one)
  • poly(lactic-co-glycolic acid)
  1. MMWLpvBdSlxcxC
  2. Azi
  3. Zg8ED
  4. QavOwK5WIg
Product

gemcitabine-loaded PLGA nanoparticles

Diameter: 194.5 - 213.5 nm

Medium/Support: none

Method 3

Type: Physical formation
Source:
Starting materials
  • poly(lactic-co-glycolic acid)
  • (4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl]-1,2-dihydropyrimidin-2-one)
  1. 3MDvjRid8aCYsl
  2. y1f
  3. lPrs4
  4. YGJWycxZd4
Product

gemcitabine-loaded PLGA nanoparticles

Diameter: 197.1 - 216.1 nm

Medium/Support: none

Method 4

Type: Physical formation
Source:
Starting materials
  • (4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl]-1,2-dihydropyrimidin-2-one)
  • poly(lactic-co-glycolic acid)
  1. CJ6Ru8sudnZGCz
  2. BZO
  3. cjiZ6
  4. fejOSPVP3P
Product

gemcitabine-loaded PLGA nanoparticles

Diameter: 210.5 - 221.5 nm

Medium/Support: none

Method 5

Type: Physical formation
Source:
Starting materials
  • poly(lactic-co-glycolic acid)
  • (4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl]-1,2-dihydropyrimidin-2-one)
  1. tL5VSnJeUN4J6Q
  2. JxE
  3. kcLRe
  4. csDoK5MwFU
Product

gemcitabine-loaded PLGA nanoparticles

Diameter: 168 - 188 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial